PharmaMar today announces the presentation of five posters highlighting advances with three of its compounds at the 97th Annual Meeting of the American Association for Cancer Research (AACR), taking place in Washington from 1-5 April 2006. The posters include results from preclinical research on Aplidin(R), Zalypsis(R) and PM02734.
